Characterization of baseline CTCs according to the EMT phenotype predicted the effective period of standard ADT for patients newly diagnosed with metastatic CSPC. These findings are important for counselling patients and designing clinical trials.
Keyphrases
- newly diagnosed
- prostate cancer
- end stage renal disease
- clinical trial
- chronic kidney disease
- ejection fraction
- squamous cell carcinoma
- randomized controlled trial
- induced apoptosis
- radical prostatectomy
- patient reported outcomes
- oxidative stress
- cell proliferation
- human immunodeficiency virus
- patient reported
- study protocol
- endoplasmic reticulum stress
- men who have sex with men
- phase ii
- placebo controlled